Search

everythinglearnresearchcommunity

for

Search:↓

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Ultrasonography in dermatology improves diagnosis and treatment of skin conditions.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

New techniques for treating scalp blood vessel malformations are effective and can have good cosmetic results.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Robotics in facial injections offers precision but is costly and lacks personal touch.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Diagonal earlobe crease and lipoprotein(a) together help diagnose coronary heart disease.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

PCOS-related infertility is managed with lifestyle changes and medications.

Concentrated growth factors can effectively treat hair loss caused by filler injections.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Metal-organic frameworks help heal wounds by effectively delivering medicine.